Springe direkt zu Inhalt

First-patient-in for our ON-TARGET study (TDM in clinical practice)

News from Apr 26, 2021

The first patient has been included in the ON-TARGET study, a non-interventional study on Therapeutic Drug Monitoring in patients with renal cell carcinoma and on the feasibility of using Volumetric Absorptive Microsampling (VAMS) for sample collection.  The ON-TARGET study is the joint project of a network of clinical and academic experts in oral tumour therapy, pharmacometric data analysis, bioanalysis, and clinical studies within the framework of the Central European Society for Anticancer Drug Research (CESAR).

2 / 4